4.6 Review

Dietary fiber in irritable bowel syndrome

Journal

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Volume 40, Issue 3, Pages 607-613

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2017.3072

Keywords

microbiota; enteric nervous system; fermentation; immune system; intestinal endocrine cells; laxation; meteorism; psyllium

Funding

  1. Helse-Vest, Norway [911978]
  2. Helse-Fonna Norway [40415]

Ask authors/readers for more resources

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. It is widely believed that IBS is caused by a deficient intake of dietary fiber, and most physicians recommend that patients with IBS increase their intake of dietary fiber in order to relieve their symptoms. However, different types of dietary fiber exhibit marked differences in physical and chemical properties, and the associated health benefits are specific for each fiber type. Short-chain soluble and highly fermentable dietary fiber, such as oligosaccharides results in rapid gas production that can cause abdominal pain/discomfort, abdominal bloating/distension and flatulence in patients with IBS. By contrast, long-chain, intermediate viscous, soluble and moderately fermentable dietary fiber, such as psyllium results in a low gas production and the absence of the symptoms related to excessive gas production. The effects of type of fiber have been documented in the management of IBS, and it is known to improve the overall symptoms in patients with IBS. Dietary fiber acts on the gastrointestinal tract through several mechanisms, including increased fecal mass with mechanical stimulation/irritation of the colonic mucosa with increasing secretion and peristalsis, and the actions of fermentation byproducts, particularly short-chain fatty acids, on the intestinal microbiota, immune system and the neuroendocrine system of the gastrointestinal tract. Fiber supplementation, particularly psyllium, is both safe and effective in improving IBS symptoms globally. Dietary fiber also has other health benefits, such as lowering blood cholesterol levels, improving glycemic control and body weight management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Gastroenterology & Hepatology

Fecal microbiota transplantation for managing irritable bowel syndrome

Magdy El-Salhy, Tarek Mazzawi

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Multidisciplinary Sciences

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

Tarek Mazzawi, Gulen Arslan Lied, Dag Andre Sangnes, Magdy El-Salhy, Johannes R. Hov, Odd Helge Gilja, Jan Gunnar Hatlebakk, Trygve Hausken

PLOS ONE (2018)

Article Gastroenterology & Hepatology

Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels

Tarek Mazzawi, Trygve Hausken, Johannes R. Hov, Jorgen Valeur, Dag Andre Sangnes, Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk, Gulen Arslan Lied

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation

Tarek Mazzawi, Oystein Eikrem, Gulen Arslan Lied, Trygve Hausken

GASTROENTEROLOGY RESEARCH AND PRACTICE (2020)

Editorial Material Gastroenterology & Hepatology

EUS-guided transhepatic antegrade stenting of dilated intrahepatic duct due to a pancreatic head malignancy (with videos)

Tarek Mazzawi, Auamduan Chaiyapo, Pradermchai Kongkam, Wiriyaporn Ridtitid, Rungsun Rerknimitr

ARAB JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Elastography of pancreatic ductal adenocarcinoma following EUS-guided radiofrequency ablation (with video)

Tarek Mazzawi, Auamduan Chaiyapo, Pradermchai Kongkam, Wiriyaporn Ridtitid, Rungsun Rerknimitr

ARAB JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation

Tarek Mazzawi, Trygve Hausken, Magdy El-Salhy

Summary: This study aimed to investigate the effect of fecal microbiota transplantation (FMT) on colonic enteroendocrine cells densities in patients with irritable bowel syndrome (IBS). The results showed significant changes in colonic enteroendocrine cells densities in the group of responders who received donor-FMT. However, the mechanisms behind the interaction between gut microbiota and colonic enteroendocrine cells still need further investigation.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms

Magdy El-Salhy, Tarek Mazzawi, Trygve Hausken, Jan Gunnar Hatlebakk

Summary: This study aimed to investigate the differences in FMT response between patients with severe and moderate IBS symptoms. The results showed that patients with severe symptoms had a higher response rate to FMT and experienced significant improvement in fatigue and quality of life.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2022)

Review Microbiology

Gut Microbiota Manipulation in Irritable Bowel Syndrome

Tarek Mazzawi

Summary: Research suggests that manipulating gut microbiota can improve symptoms of irritable bowel syndrome (IBS), with dietary management and other approaches showing promise in changing gut composition and alleviating IBS symptoms. However, more research is needed to identify the exact mixture of beneficial bacteria.

MICROORGANISMS (2022)

Article Microbiology

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study

Tarek Mazzawi, Trygve Hausken, Per Forde Refsnes, Jan Gunnar Hatlebakk, Gulen Arslan Lied

Summary: This study compared the efficacy and safety of ACHIM suspension, donor-FMT, and placebo in the treatment of IBS. The results showed that all three treatment methods improved the symptoms and gut microbiota profile of IBS patients, but donor-FMT and ACHIM were more significant compared to placebo.

MICROORGANISMS (2022)

Article Gastroenterology & Hepatology

EUS-guided coil placement for acute gastric variceal bleeding induced by non-EUS-guided variceal glue injection (with video)

Tarek Mazzawi, Carl Erik Markhus, Roald F. Havre, Khanh Do-Cong Pham

ENDOSCOPY INTERNATIONAL OPEN (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Gastric Emptying of Low- and High-Caloric Liquid Meals Measured Using Ultrasonography in Healthy Volunteers

Tarek Mazzawi, Emily Bartsch, Sara Benammi, Rosa Maria Carrasco Ferro, Ekaterina Nikitina, Nancy Nimer, Lara Jimenez Ortega, Charles Perrotte, Joao Vitor Pithon, Safira Rosallna, Alexis Sharp, Reza Stevano, Jan Gunnar Hatlebakk, Trygve Hausken

ULTRASOUND INTERNATIONAL OPEN (2019)

Meeting Abstract Gastroenterology & Hepatology

Effect of faecal microbiota transplantation on gut microenvironment and symptoms in patients with Irritable Bowel Syndrome

T. Mazzawi, G. Lied Arslan, J. R. Hov, J. Valeur, D. A. Sangnes, M. El-Salhy, O. H. Gilja, J. G. Hatlebakk, T. Hausken

NEUROGASTROENTEROLOGY AND MOTILITY (2018)

Meeting Abstract Gastroenterology & Hepatology

DIAGNOSTIC YIELD OF EUS-GUIDED MICRO-BIOPSIES IN PANCREATIC CYSTS

Roald F. Havre, Hilde K. Gjelberg, Trond Engjom, Tarek Mazzawi, Dag Hoem, Kim Waardal, Anders Molven, Khanh Cong Do Pham

GASTROINTESTINAL ENDOSCOPY (2018)

Meeting Abstract Gastroenterology & Hepatology

Effect of faecal microbiota transplantation on the enteroendocrine cells of the colon in patients with Irritable Bowel Syndrome (IBS): Double blinded-placebo controlled study

M. El-Salhy, P. Holger Johnsen, T. Mazzawi, M. El-Salhy, T. Hausken, R. Goll, P. C. Valle

NEUROGASTROENTEROLOGY AND MOTILITY (2017)

No Data Available